Elinx Stock

Elinx ROA

The Return on Assets (ROA) of Elinx (ELNX) as of Aug 21, 2026 is -230.21 %.

ROA

-230.21 %

Last updated:

In 2026, Elinx's return on assets (ROA) was -230.21 %, a % increase from the - ROA in the previous year.

Access this data via the Eulerpool API

Elinx Stock analysis

What does Elinx do? Aperture Health Inc. is a globally operating company in the healthcare industry based in San Francisco, California. The company was founded in 2014 by a group of healthcare experts with the goal of revolutionizing healthcare. Since its inception, the company has experienced rapid growth and is now a major player in the healthcare market. Aperture Health Inc.'s business model is based on the development and sale of innovative products and services in the healthcare sector. The company operates in multiple business fields, all aiming to improve healthcare. This includes digital health, clinical diagnostic tests, healthcare, and health insurance. In the field of digital health, the company offers a wide range of solutions aimed at simplifying healthcare management. These solutions include mobile health applications that allow users to monitor and track their health data. The company is also working on the development of personalized medical devices and wearables that help diagnose and treat various health issues. Aperture Health Inc. is also involved in the development and manufacturing of clinical diagnostic tests. The company has developed a wide range of diagnostic tests for diseases such as cancer, diabetes, and HIV. These tests are fast and easy to perform and provide accurate results. In the area of healthcare, the company provides a wide range of services aimed at improving the quality of healthcare. These services include access to specialized medical professionals, assistance in organizing doctor visits, and prescription of medications. Aperture Health Inc. works closely with hospitals and medical facilities to provide seamless and high-quality healthcare. Aperture Health Inc. also offers innovative health insurance tailored to the needs of customers. These insurances combine a wide range of health insurance options that meet the customers' needs with an intelligent health management system that allows policyholders to monitor and improve their health. The company is also engaged in research and development of new treatment methods. Aperture Health Inc. collaborates closely with medical research institutions and professionals to develop new and innovative treatment methods that aim to improve healthcare globally. In summary, Aperture Health Inc. is a company that aims to revolutionize healthcare worldwide. The company offers innovative products and services aimed at improving people's health and increasing their quality of life. With a wide range of solutions in various business fields, Aperture Health Inc. has become a major player in the healthcare industry and will continue to play an important role in the future. Elinx is one of the most popular companies on Eulerpool.

ROA Details

Understanding Elinx's Return on Assets (ROA)

Elinx's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Elinx's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Elinx's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Elinx’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Elinx stock

Return on Assets (ROA) of Elinx is -230.21 % in 2026.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Elinx since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Elinx with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

Profitability — Elinx

All Key Metrics — Elinx